Obesity and the increased postprandial glycaemic response (PPGR) are risk factors for type 2 diabetes. Few studies have explored the association of body weight with PPGRs. The study aimed to investigate the PPGR between healthy adults with normal weight and overweight/obesity to two commercially available breads (white and wholemeal) with different dietary fibre contents. In this acute randomised crossover trial, 20 healthy adults (10 normal weight, 10 overweight/obese) consumed two slices of white (100 g, fibre 3.6 g) or wholemeal bread (88 g, fibre 5.6 g) alongside 150 ml of orange juice and 10 g butter on separate visits in random order after fasting for 8-12 hours. The blood glucose concentration was measured fasted, 30 min, 60 min, 90 min and 120 min postprandially by finger pricks. Information on age, gender, ethnicity, body mass index (BMI), and body fat percentage were collected. Two-way repeated measures ANCOVA was used for controlling for age, gender, ethnicity and body fat percentage, and results showed no significant difference was observed in fasting blood glucose concentrations (F(1, 14)=2.968, P=0.107), incremental areas under the curve (iAUCs) (F (1, 14) = 0.702, P=0.416) and peak values (PVs) (F (1, 14) = 0.507, P=0.488) between participants with normal weight and overweight/obesity, or in fasting blood glucose concentrations (F(1, 14)=0.007, P=0.964), iAUCs (F (1, 14) = 0.008, P=0.929) and PVs (F (1, 14) = 0.036, P=0.851) between white and wholemeal bread consumption. The BMI or body fat percentage was not associated with iAUCs or PVs regardless of bread type adjusted by age, gender and ethnicity. Our results did not find that body weight is associated with PPGR in healthy adults, and the wholemeal bread used in the current study did not deliver the health benefit of attenuating PPGR compared with white bread consumption despite the higher dietary fibre content.

The authors have declared no competing interest.

This study was funded by Nutrition Society Summer Studentship 2022 (Ref 71978).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Coventry University Ethics Committee (Ref P136390).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.